Is the tide of innovation in the dietary supplement industry waxing or waning? An expert says that there is plenty of innovation happening if you are willing to look hard enough.
Dr Dan Fabricant, PhD, executive director of the Natural Products Association, has continued his forceful advocacy of existing compliant paths to market for CBDs in an appearance on The Doctors TV show.
The Natural Algae Astaxanthin Association has filed a citizen’s petition that seeks regulatory action by FDA against a synthetic form of astaxanthin marketed by Cardax.
The tussle between ChromaDex and Elysium Health highlights again the curious dance between a New Dietary Ingredient Notification and a GRAS affirmation as a way to bring ingredients to market.
The good news in the botanicals sector is that increasing numbers of systematic reviews and meta-analyses show that there is strong support for the health benefits of these ingredients, said Mark Blumenthal, founder of the American Botanical Council.
Experts expect the existing standoff on synthetic botanicals as voiced by FDA in the most recent draft NDI guidance will continue, despite the consensus from industry being the agency’s position is not rooted in science.
A federal district court judge in Atlanta has ruled in favor of FDA in its case against Hi-Tech Pharmaceuticals over its use of DMAA. But the ruling potentially weakens agency’s stance on the question of synthetic versions of constituents of botanicals.
A call from the U.S. Commerce Department for suggestions on streamlining manufacturing regulations has generated responses from industry trade organizations, with the different tacks the suggestions take reflecting those organizations’ membership.
Openness and transparency is the only way for genetic engineering technology to thrive in the supply of dietary ingredients, said an official with a company engaged in the practice.
The updated New Dietary Ingredients draft guidance is an attempt to over regulate and weaken the dietary supplement industry with no increase in public safety, according to comments filed recently by finished goods manufacturer Jarrow Formulas.
Oxford researchers behind a novel performance-enhancing ketone drink get around an email a day from sports teams hoping to buy the product – and another 20-30 unnamed professional teams have already been involved in research trials with the product.
Requiring NDI notifications on almost every new product will create a situation in which few companies will be able to comply with the new draft guidance, the United Natural Products Alliance said.
The Natural Products Association has urged FDA to cease its attempt to apply food additive standards to dietary ingredients. To do so would create an undue burden on small business, many of which are represented by NPA.
Zivo Bioscience, an algae company long focused on deriving unique bioactives from its proprietary strains, has pivoted to protein as developers realized the potential inherent in the straight, unrefined biomass.
The Council for Responsible Nutrition has submitted comments to a Health Canada that urges the agency not to scrap the existing product registration system but rather to further refine it if that is deemed necessary and to better educate the public about...
The updated New Dietary Ingredients draft guidance, issued yesterday by the Food and Drug Administration, modifies the agency’s stance on the contentious issue of synthetic, nature-identical compounds. But not by much.
News that Senators Dick Durbin and Richard Blumenthal plan to introduce legislation for the dietary supplement industry came as no surprise to executives of industry trade associations.
Despite an import ban on the substance, kratom-containing products continue to find their way into the country. In the latest action, the Food and Drug Administration has seized 90,000 bottles at a facility in Illinois.
What’s the future for botanical ingredient discovery? Experts differ on whether there are wholly new, useful species yet to be discovered, but agree that there are still more ingredients to be derived from source materials already in use.
The actions of New York Attorney General Eric Schneiderman have put an unprecedented pressure on the dietary supplement business, especially those companies dealing in herbal products.
The USPLabs case demonstrates the tools investigators and prosecutors can bring to bear when looking into the dealings of a dietary supplement company, a former prosecutor says.
GNC laid out a blueprint for the dietary supplement industry for a quality initiative including pre-market product registration at a meeting last week in Salt Lake City. The initiative builds upon GNC’s agreement with the NY AG office and is meant to...
The Vitamin Shoppe CEO Colin Watts said a slow pace of innovation in the supplements industry has hurt the company, which has relied on a rapid pace of new product launches to keep its shelves fresh. The company reported third quarter earnings that were...
Former FDA official Dr Joshua Sharfstein, MD, has proposed a new paradigm for the regulation of dietary supplements. The underlying shift would be a move from an attitude of “benefit versus risk” to one of “access with safety.”
The declaration from FDA on picamilon that formed part of the lawsuit filed by the Oregon Attorney General sets a troubling precedent, said Steve Mister of the Council for Responsible Nutrition.
The lawsuit filed by the Oregon Attorney General raises overall risk for the supplements industry and could mean that a number of niche ingredients could disappear from the market, experts said.
Cara Welch, PhD, acting deputy director of the Division of Dietary Supplement Programs at the Food and Drug Administration, signaled a change in emphasis at the agency with a willingness to publicly acknowledge the dietary supplement industry’s GMP successes...
Nailing down a precise nomenclature for herbs is a complicated undertaking, and the best good faith efforts of industry may have unwittingly given an opening to the NY AG Eric Schneiderman in his continuing offensive against the dietary supplement industry.
Discussions continue within the industry whether some form of pre-market notification could be a valuable modification of existing dietary supplement regulations. But rifts are appearing over whether the implementation of such a system might unfairly...
University of Toronto start-up Nutrigenomix is a pioneer in the personalized nutrition space that is helping consumers understand how variations in their genes influence their bodies’ response to food, beverages and supplements, and in doing so is helping...
The Irish biotech Nuritas is changing how novel food-based ingredients with health-benefits are discovered and in doing so is revolutionizing innovation in the supplement space.
Is it time to consider new legislation to alter the landscape that DSHEA created for the dietary supplements industry? The issue was raised in a recent public industry forum and met a generally positive reception.
The Natural Algae Astaxanthin Association (NAXA) is aiming to rekindle its momentum with the naming of a new president. Longtime industry insider Scott Steinford, who is also president of the recently formed CoQ10 Association, has taken the job, effective...
An executive with one of the companies promoting cannabidiol for dietary supplements believes that FDA’s recent determination that the compound is not a legal dietary ingredient is premature and will be overturned.
The Food and Drug Administration announced Wednesday that it has banned the use of the stimulant BMPEA in dietary supplements and foods. The agency also sent five warning letters to companies that have used the variant of amphetamine in weight loss supplements. ...
For those monitoring the potential market of dietary supplements based on cannabidiol the message is this: Don’t hold your breath for products made in the US, if the experience of Colorado industrial hemp growers is any benchmark. The complex and in some...
Bioavailability enhancements continue to be one of the most active development tangents in the dietary supplement ingredient industry. But even as these approaches gain market traction, basic information about the toxicological profiles of many of these...
The constituents of herbal dietary supplements continues to be a point of confusion and contention among those viewing the industry from the outside and was identified as a key point of industry vulnerability during a session of a recent science conference...
US Senators Dick Durbin and Richard Blumenthal sent a letter yesterday to the Food and Drug Administration asking the agency to take action against products containing the synthetic stimulant ingredient known as BMPEA, products which the pair called both “mislabeled...
The controversy surrounding the low-profile botanical Acacia rigidula and its purported amphetamine-like constituents seems to have caught regulators flat footed and has lead one trade association to ban the sale for its members of formulations featuring...
Prominent dietary supplement industry critic Dr Pieter Cohen has released a new study that shows that a synthetic stimulant was found in more than half of weight loss and sports performance products tested that listed Acacia rigidula as an ingredient...
Qualitas Health, a supplier of a unique polar-lipid structured algal omega-3 ingredient, is now at full scale production and is participating in what an executive calls “the future of omega-3s.”
The high rate of failure in New Dietary Ingredient notifications has led some companies to seek workarounds. Anecdotal evidence gathered by NutraIngredients-USA shows that companies are increasingly leaning on GRAS status as a way to avoid having to enter...
The Food and Drug Administration has issued another warning letter taking a company to task for marketing a product with an ingredient that lacks a New Dietary Ingredient filing. But one observer wonders why more such letters haven’t come from the agency.
